![#344 - [Neonatal Nephrology Shorts] - 📌 PDA Treatment in ELGANs and Long-Term Kidney Function at Two Years cover art](https://m.media-amazon.com/images/I/41adZE--r1L._SL500_.jpg)
#344 - [Neonatal Nephrology Shorts] - 📌 PDA Treatment in ELGANs and Long-Term Kidney Function at Two Years
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
#344 - [Neonatal Nephrology Shorts] - 📌 PDA Treatment in ELGANs and Long-Term Kidney Function at Two Years
-
Narrated by:
-
By:
About this listen
Send us a text
Association of patent ductus arteriosus treatment in extremely low gestational age neonates with two year kidney outcomes: a secondary analysis of the preterm erythropoietin neuroprotection trial (PENUT).
Condit PE, Guillet R, Kaluarachchi D, Griffin RL, Menon S, Askenazi DJ, Harer MW.BMC Nephrol. 2025 Mar 19;26(1):138. doi: 10.1186/s12882-025-04065-8.PMID: 40108500 Free PMC article. Clinical Trial.
Support the show
As always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.
Enjoy!